Chinese- REPORT SUMMARY
- TABLE OF CONTENTS
-
The report details the trend, potential and market size of Antidiabetics market, and analyzes the current situation and prospects of the market from both qualitative and quantitative aspects, which can be roughly divided into three parts.
The first part (Chapter1-7) mainly covers the qualitative analysis of Antidiabeticsmarket, defines the market attractiveness level of Antidiabetics market through Porter's Five Forces Analysis, and summarizes the different factors in the overall environment through PEST analysis. Understand the distribution of industrial chain value in each link of industrial chain through the analysis of industrial chain structure. Thus estimate the market space of each link.
The second part (Chapter8-12), based on the segmentation of Antidiabetics industry, describes the types of Antidiabetics market, the applications of major players and the market size, and deeply analyzes the current situation of the global Antidiabetics market and the development prospects and opportunities of Antidiabetics industry.
The third part (Chapter14-15) includes the market positions of the major players and information on the market participants, which will help you gain a comprehensive understanding of the current competitive situation and potential growth opportunities in the market.
As COVID-19 continues to impact the global economy in 2022, the report also considers the short - and long-term impacts of COVID-19 on the global Antidiabetics market in Chapter 13.
By Player:
Sanofi-Aventis
Eli Lilly
Halozyme Therapeutics
Takeda Pharmaceuticals
Pfizer
Oramed Pharmaceuticals
Merck & Co Inc
Novo Nordisk
Boehringer Ingelheim
Bristol-Myers Squibb
By Type:
Type 1 Diabetes
Type 2 Diabetes
Other
By End-User:
Hospital Use
Clinic Use
Household
Other
By Geography:
-
United States
-
Europe
-
China
-
Japan
-
India
-
South Korea
TABLE OF CONTENT
1 Introduction
-
1.1 Market Definition
-
1.2 Market Segment Analysis
-
1.3 Market Size 2022
-
1.4 Antidiabetics Market Outlook: Forecast for 2022 - 2028
-
1.5 Pricing Analysis
2 Executive Summary
3 Antidiabetics Market Lineage Outlook
-
3.1 Parent Market Outlook
-
3.2 Related/Ancillary Market Outlook
-
3.3 Penetration & Growth Prospect Mapping, 2022
4 Market Analysis Tools: Porter's Five Forces
-
4.1 Supplier Power
-
4.2 Buyer Power
-
4.3 Substitution Threat
-
4.4 Threat of New Entrants
-
4.5 Competitive Rivalry
5 Antidiabetics Industry Analysis - PEST (Political & Legal, Economic, Social, and Technological)
-
5.1 Political/Legal Landscape
-
5.2 Economic Landscape
-
5.3 Social Landscape
-
5.4 Technology Landscape
6 Antidiabetics Market - Value Chain Analysis
-
6.1 Industry's Value Chain Analysis
-
6.2 Product Life Cycle
-
6.3 User Perspective Analysis
7 Region and Country-wise Antidiabetics Market Analysis and Outlook to 2022
-
7.1 Global Antidiabetics Consumption (2017-2022)
-
7.2 United States Antidiabetics Consumption (2017-2022)
-
7.3 Europe Antidiabetics Consumption (2017-2022)
-
7.4 China Antidiabetics Consumption (2017-2022)
-
7.5 Japan Antidiabetics Consumption (2017-2022)
-
7.6 India Antidiabetics Consumption (2017-2022)
-
7.7 South Korea Antidiabetics Consumption (2017-2022)
8 Region and Country-wise Antidiabetics Market Analysis and Outlook to 2028
-
8.1 Global Antidiabetics Consumption Forecast (2022-2028)
-
8.2 United States Antidiabetics Consumption Forecast (2022-2028)
-
8.3 Europe Antidiabetics Consumption Forecast (2022-2028)
-
8.4 China Antidiabetics Consumption Forecast (2022-2028)
-
8.5 Japan Antidiabetics Consumption Forecast (2022-2028)
-
8.6 India Antidiabetics Consumption Forecast (2022-2028)
-
8.7 South Korea Antidiabetics Consumption Forecast (2022-2028)
9 Global Antidiabetics Market Outlook by Types and Applications to 2022
-
9.1 Global Antidiabetics Consumption and Growth Rate by Type (2017-2022)
-
9.1.1 Global Type 1 Diabetes Consumption and Growth Rate (2017-2022)
-
9.1.2 Global Type 2 Diabetes Consumption and Growth Rate (2017-2022)
-
9.1.3 Global Other Consumption and Growth Rate (2017-2022)
-
9.2 Global Antidiabetics Consumption and Growth Rate by Application (2017-2022)
-
9.2.1 Global Hospital Use Consumption and Growth Rate (2017-2022)
-
9.2.2 Global Clinic Use Consumption and Growth Rate (2017-2022)
-
9.2.3 Global Household Consumption and Growth Rate (2017-2022)
-
9.2.4 Global Other Consumption and Growth Rate (2017-2022)
10 Global Antidiabetics Market Outlook by Types and Applications to 2028
-
10.1 Global Antidiabetics Consumption Forecast and Growth Rate by Type (2022-2028)
-
10.1.1 Global Type 1 Diabetes Consumption Forecast and Growth Rate (2022-2028)
-
10.1.2 Global Type 2 Diabetes Consumption Forecast and Growth Rate (2022-2028)
-
10.1.3 Global Other Consumption Forecast and Growth Rate (2022-2028)
-
10.2 Global Antidiabetics Consumption Forecast and Growth Rate by Application (2022-2028)
-
10.2.1 Global Hospital Use Consumption Forecast and Growth Rate (2022-2028)
-
10.2.2 Global Clinic Use Consumption Forecast and Growth Rate (2022-2028)
-
10.2.3 Global Household Consumption Forecast and Growth Rate (2022-2028)
-
10.2.4 Global Other Consumption Forecast and Growth Rate (2022-2028)
11 Global Antidiabetics Import and Export Analysis (Top 5 Countries)
-
11.1 Global Antidiabetics Import by Region (Top 5 Countries) (2017-2028)
-
11.2 Global Antidiabetics Export by Region (Top 5 Countries) (2017-2028)
12 Coronavirus Disease (COVID-19) Impact
-
12.1 Industry Impact Analysis
-
12.2 Antidiabetics Market Outlook to 2028 - COVID-19 Affected Forecasts
13 Competition Matrix
-
13.1 Target Markets
-
13.2 Comprehensive Analysis of Products in Competitive Markets
14 Global Antidiabetics Market Competitive Analysis
-
14.1 Sanofi-Aventis
-
14.1.1 Sanofi-Aventis Company Details
-
14.1.2 Sanofi-Aventis Antidiabetics Sales, Price, Value and Gross Profit (2017-2022)
-
14.1.3 Sanofi-Aventis Antidiabetics Product and Service
-
14.2 Eli Lilly
-
14.2.1 Eli Lilly Company Details
-
14.2.2 Eli Lilly Antidiabetics Sales, Price, Value and Gross Profit (2017-2022)
-
14.2.3 Eli Lilly Antidiabetics Product and Service
-
14.3 Halozyme Therapeutics
-
14.3.1 Halozyme Therapeutics Company Details
-
14.3.2 Halozyme Therapeutics Antidiabetics Sales, Price, Value and Gross Profit (2017-2022)
-
14.3.3 Halozyme Therapeutics Antidiabetics Product and Service
-
14.4 Takeda Pharmaceuticals
-
14.4.1 Takeda Pharmaceuticals Company Details
-
14.4.2 Takeda Pharmaceuticals Antidiabetics Sales, Price, Value and Gross Profit (2017-2022)
-
14.4.3 Takeda Pharmaceuticals Antidiabetics Product and Service
-
14.5 Pfizer
-
14.5.1 Pfizer Company Details
-
14.5.2 Pfizer Antidiabetics Sales, Price, Value and Gross Profit (2017-2022)
-
14.5.3 Pfizer Antidiabetics Product and Service
-
14.6 Oramed Pharmaceuticals
-
14.6.1 Oramed Pharmaceuticals Company Details
-
14.6.2 Oramed Pharmaceuticals Antidiabetics Sales, Price, Value and Gross Profit (2017-2022)
-
14.6.3 Oramed Pharmaceuticals Antidiabetics Product and Service
-
14.7 Merck & Co Inc
-
14.7.1 Merck & Co Inc Company Details
-
14.7.2 Merck & Co Inc Antidiabetics Sales, Price, Value and Gross Profit (2017-2022)
-
14.7.3 Merck & Co Inc Antidiabetics Product and Service
-
14.8 Novo Nordisk
-
14.8.1 Novo Nordisk Company Details
-
14.8.2 Novo Nordisk Antidiabetics Sales, Price, Value and Gross Profit (2017-2022)
-
14.8.3 Novo Nordisk Antidiabetics Product and Service
-
14.9 Boehringer Ingelheim
-
14.9.1 Boehringer Ingelheim Company Details
-
14.9.2 Boehringer Ingelheim Antidiabetics Sales, Price, Value and Gross Profit (2017-2022)
-
14.9.3 Boehringer Ingelheim Antidiabetics Product and Service
-
14.10 Bristol-Myers Squibb
-
14.10.1 Bristol-Myers Squibb Company Details
-
14.10.2 Bristol-Myers Squibb Antidiabetics Sales, Price, Value and Gross Profit (2017-2022)
-
14.10.3 Bristol-Myers Squibb Antidiabetics Product and Service
15 Appendix
TABLE OF CHARTS
-
Table Definition of Antidiabetics
-
Figure Antidiabetics Picture
-
Table Global Antidiabetics Market Size and Forecast 2022 - 2028 (USD million)
-
Figure Global Antidiabetics Market Size and Forecast 2022 - 2028 (USD million)
-
Figure Global Antidiabetics Market: Year-over-year Growth 2022 - 2028 (%)
-
Table Parent Market Analysis
-
Figure Parent Market Price
-
Table Related/Ancillary Market Outlook Analysis
-
Table Supplier Power Analysis
-
Table Buyer Power Analysis
-
Table Substitution Threat Analysis
-
Table Threat of New Entrants Analysis
-
Table Competitive Rivalry Analysis
-
Figure Global Antidiabetics Consumption by Country (2017-2022)
-
Figure United States Antidiabetics Consumption and Growth Rate (2017-2022)
-
Table Europe Antidiabetics Consumption and Growth Rate (2017-2022)
-
Figure China Antidiabetics Consumption and Growth Rate (2017-2022)
-
Figure Japan Antidiabetics Consumption and Growth Rate (2017-2022)
-
Figure India Antidiabetics Consumption and Growth Rate (2017-2022)
-
Figure South Korea Antidiabetics Consumption and Growth Rate (2017-2022)
-
Figure Global Antidiabetics Consumption Forecast by Country (2022-2028)
-
Figure United States Antidiabetics Consumption Forecast and Growth Rate (2022-2028)
-
Table Europe Antidiabetics Consumption Forecast and Growth Rate (2022-2028)
-
Figure China Antidiabetics Consumption Forecast and Growth Rate (2022-2028)
-
Figure Japan Antidiabetics Consumption Forecast and Growth Rate (2022-2028)
-
Figure India Antidiabetics Consumption Forecast and Growth Rate (2022-2028)
-
Figure South Korea Antidiabetics Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Type 1 Diabetes Consumption and Growth Rate (2017-2022)
-
Figure Global Type 2 Diabetes Consumption and Growth Rate (2017-2022)
-
Figure Global Other Consumption and Growth Rate (2017-2022)
-
Figure Global Hospital Use Consumption and Growth Rate (2017-2022)
-
Figure Global Clinic Use Consumption and Growth Rate (2017-2022)
-
Figure Global Household Consumption and Growth Rate (2017-2022)
-
Figure Global Other Consumption and Growth Rate (2017-2022)
-
Figure Global Type 1 Diabetes Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Type 2 Diabetes Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Other Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Hospital Use Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Clinic Use Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Household Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Other Consumption Forecast and Growth Rate (2022-2028)
-
Table Global Antidiabetics Import by Region (Top 5 Countries) (2017-2028)
-
Table Global Antidiabetics Export by Region (Top 5 Countries) (2017-2028)
-
Table Sanofi-Aventis (Foundation Year, Company Profile and etc.)
-
Table Sanofi-Aventis Antidiabetics Sales, Price, Value and Gross Profit (2017-2022)
-
Table Sanofi-Aventis Antidiabetics Product and Service
-
Table Eli Lilly (Foundation Year, Company Profile and etc.)
-
Table Eli Lilly Antidiabetics Sales, Price, Value and Gross Profit (2017-2022)
-
Table Eli Lilly Antidiabetics Product and Service
-
Table Halozyme Therapeutics (Foundation Year, Company Profile and etc.)
-
Table Halozyme Therapeutics Antidiabetics Sales, Price, Value and Gross Profit (2017-2022)
-
Table Halozyme Therapeutics Antidiabetics Product and Service
-
Table Takeda Pharmaceuticals (Foundation Year, Company Profile and etc.)
-
Table Takeda Pharmaceuticals Antidiabetics Sales, Price, Value and Gross Profit (2017-2022)
-
Table Takeda Pharmaceuticals Antidiabetics Product and Service
-
Table Pfizer (Foundation Year, Company Profile and etc.)
-
Table Pfizer Antidiabetics Sales, Price, Value and Gross Profit (2017-2022)
-
Table Pfizer Antidiabetics Product and Service
-
Table Oramed Pharmaceuticals (Foundation Year, Company Profile and etc.)
-
Table Oramed Pharmaceuticals Antidiabetics Sales, Price, Value and Gross Profit (2017-2022)
-
Table Oramed Pharmaceuticals Antidiabetics Product and Service
-
Table Merck & Co Inc (Foundation Year, Company Profile and etc.)
-
Table Merck & Co Inc Antidiabetics Sales, Price, Value and Gross Profit (2017-2022)
-
Table Merck & Co Inc Antidiabetics Product and Service
-
Table Novo Nordisk (Foundation Year, Company Profile and etc.)
-
Table Novo Nordisk Antidiabetics Sales, Price, Value and Gross Profit (2017-2022)
-
Table Novo Nordisk Antidiabetics Product and Service
-
Table Boehringer Ingelheim (Foundation Year, Company Profile and etc.)
-
Table Boehringer Ingelheim Antidiabetics Sales, Price, Value and Gross Profit (2017-2022)
-
Table Boehringer Ingelheim Antidiabetics Product and Service
-
Table Bristol-Myers Squibb (Foundation Year, Company Profile and etc.)
-
Table Bristol-Myers Squibb Antidiabetics Sales, Price, Value and Gross Profit (2017-2022)
-
Table Bristol-Myers Squibb Antidiabetics Product and Service
-
